Latest filing published 12 Nov 2009 for Soligenix, INC., €45k.
Insider track record
No signal scores available.
Biotex Pharma Investments, LLC: trading record in brief
Biotex Pharma Investments, LLC discloses dealings in Soligenix, Inc. to SEC (Form 4). Between 30 July 2009 and 9 October 2009, the trades on record add up to 6 filings.
The open-market record consists of 2 sales worth €142k, with no purchase.
Most recently, on 12 November 2009, the filings show a transaction worth €45k in Soligenix, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 9 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Biotex Pharma Investments, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 250,000 shares@ US$0.2653Common StockSEC:0001140361-09-025694:0
- 335,000 shares@ US$0.317Common StockSEC:0001009448-09-000080:0
- 250,000 shares@ US$0.262Common StockSEC:0001009448-09-000078:0
- 750,000 shares@ US$0.3087Common StockSEC:0001009448-09-000078:1
- 500,000 shares@ US$0.2049Common StockSEC:0001009448-09-000060:0
- 500,000 shares@ US$0.20Common StockSEC:0001009448-09-000060:1
6 of 6 declarations